Cancer is the second leading cause of death in the world and one of the major public health
problems. Despite the great advances in cancer therapy, the incidence and mortality rates of …

Cancer is a major burden of disease globally. Each year, tens of millions of people are
diagnosed with cancer worldwide, and more than half of the patients eventually die from it …

This review addresses the oncopharmacological properties of curcumin at the molecular
level. First, the interactions between curcumin and its molecular targets are addressed on …

Curcumin, a yellow substance belonging to the polyphenols superfamily, is the active
component of turmeric, a common Indian spice, which is derived from the dried rhizome of …

Curcumin therapy in animals has produced positive cognitive and behavioural outcomes;
results of human trials, however, have been inconsistent. In this study, we report the results …

Cancer is the world's second leading cause of mortality and one of the major public health
problems. Cancer incidence and mortality rates remain high despite the great …

Cancer is a multifactorial disease that requires treatments able to target multiple intracellular
components and signaling pathways. The natural compound, curcumin, was already …

Background Curcumin inhibits growth of several cancer cell lines, and studies in this
laboratory in bladder and pancreatic cancer cells show that curcumin downregulates …

Curcumin has attracted great attention in the therapeutic arsenal in clinical oncology due to
its chemopreventive, antitumoral, radiosensibilizing and chemosensibilizing activities …

Curcumin (diferuloylmethane) is the main constituent extracted from turmeric. This
polyphenol is a non-toxic, potent compound with anticancer, anti-inflammatory, antibacterial …